Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00728663
What this trial is testing

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 35
Not applicableStudy completedNCT02398526
What this trial is testing

Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases

Who this might be right for
Castration-Resistant Prostatic Cancer
Bayer 363
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Early research (Phase 1)Study completedNCT02184533
What this trial is testing

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+3 more
Stanford University 15
Testing effectiveness (Phase 2)Ended earlyNCT01469338
What this trial is testing

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

Who this might be right for
DiarrheaHormone-resistant Prostate CancerRecurrent Prostate Cancer+5 more
University of Southern California 9
Early research (Phase 1)Ended earlyNCT04575766
What this trial is testing

FT-7051 in Men With MCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Novo Nordisk A/S 25
Early research (Phase 1)Looking for participantsNCT07339267
What this trial is testing

Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 12
Not applicableStudy completedNCT03154190
What this trial is testing

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Who this might be right for
Acute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more
Stanford University 128
Large-scale testing (Phase 3)Ended earlyNCT00626548
What this trial is testing

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 2,577
Testing effectiveness (Phase 2)UnknownNCT00218205
What this trial is testing

Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Department of Veterans Affairs, New Jersey 28
Testing effectiveness (Phase 2)Study completedNCT01075308
What this trial is testing

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 32
Early research (Phase 1)Looking for participantsNCT05997615
What this trial is testing

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
Astellas Pharma Global Development, Inc. 437
Testing effectiveness (Phase 2)Looking for participantsNCT06702995
What this trial is testing

Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate-Resistant Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)
Evopoint Biosciences Inc. 307
Not applicableActive Not RecruitingNCT07352748
What this trial is testing

Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa

Who this might be right for
Metastatic Prostate Cancer
Universita di Verona 30
Testing effectiveness (Phase 2)Study completedNCT02159950
What this trial is testing

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 2
Not applicableWithdrawnNCT05245435
What this trial is testing

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna
Testing effectiveness (Phase 2)Study completedNCT00006023
What this trial is testing

Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Swiss Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT01083615
What this trial is testing

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Castrate-Resistant Prostate CancerHormone Refractory Prostate Cancer
Achieve Life Sciences 14
Not applicableEnded earlyNCT00743327
What this trial is testing

Androgen Deprivation Therapy Study

Who this might be right for
HypogonadismMetabolic SyndromeDiabetes+1 more
National Institute on Aging (NIA) 1
Next Page